Cost Benefit Evaluation of Cognate Drugs Prescribed for Medicaid Beneficiaries with Alzheimer’s Disease (AD) and Other Dementias

Authors

Marion Becker, University of South FloridaFollow
Ross Andel, University of South Florida
Lodi Rohrer, University of South Florida

Document Type

Technical Report

Publication Date

2005

Was this content written or created while at USF?

Yes

Citation / Publisher Attribution

Louis de la Parte Florida Mental Health Institute, 37 p.

Scholar Commons Citation

Becker, Marion; Andel, Ross; and Rohrer, Lodi, "Cost Benefit Evaluation of Cognate Drugs Prescribed for Medicaid Beneficiaries with Alzheimer’s Disease (AD) and Other Dementias" (2005). Mental Health Law & Policy Faculty Publications. 589.
https://digitalcommons.usf.edu/mhlp_facpub/589